Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial
出版年份 2013 全文链接
标题
Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 16, Issue 4, Pages 334-343
出版商
Wiley
发表日期
2013-10-12
DOI
10.1111/dom.12221
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans
- (2013) Benjamin S. Maciejewski et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study
- (2012) H. Denison et al. DIABETES OBESITY & METABOLISM
- Effects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes
- (2012) David Bradley et al. GASTROENTEROLOGY
- Fecal Markers: Calprotectin and Lactoferrin
- (2012) Bincy P. Abraham et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- DGAT1 mutation is linked to a congenital diarrheal disorder
- (2012) Joel T. Haas et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying
- (2012) Gene P. Ables et al. JOURNAL OF LIPID RESEARCH
- The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma
- (2012) Lars Löfgren et al. JOURNAL OF LIPID RESEARCH
- Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to a Clinical Candidate Dimethylpyrazinecarboxamide Phenylcyclohexylacetic Acid (AZD7687)
- (2012) Jonas G. Barlind et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea
- (2012) Sanjeev S Pattni et al. Clinical and Translational Gastroenterology
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases
- (2011) Jingsong Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle
- (2011) Li Liu et al. JOURNAL OF LIPID RESEARCH
- Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia and hepatic steatosis in db/db mice
- (2010) Xiao-dong Zhang et al. ACTA PHARMACOLOGICA SINICA
- Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels
- (2010) JWA van der Hoorn et al. BRITISH JOURNAL OF PHARMACOLOGY
- New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease
- (2010) Darla R. Shores et al. INFLAMMATORY BOWEL DISEASES
- Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion
- (2009) Mayumi Okawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor
- (2008) Gang Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started